Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

April 05, 2012

MYLAN PHARMACEUTICALS INC. v. SEBELIUS et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. June 08, 2012

    Mylan, Teva Settle Over Generic Provigil Market Rights

    Mylan Inc. has settled its dispute with Teva Pharmaceuticals USA Inc. concerning its suit against the U.S. Food and Drug Administration over allegations that Teva and subsidiary Cephalon Inc. worked to stymie generic competition of the sleep disorder drug Provigil, Mylan said Friday.

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login